BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19287191)

  • 21. Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma.
    Liu XF; Zhang H; Zhu SG; Zhou XT; Su HL; Xu Z; Li SJ
    World J Gastroenterol; 2006 Aug; 12(29):4706-9. PubMed ID: 16937443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma.
    Goeppert B; Ernst C; Baer C; Roessler S; Renner M; Mehrabi A; Hafezi M; Pathil A; Warth A; Stenzinger A; Weichert W; Bähr M; Will R; Schirmacher P; Plass C; Weichenhan D
    Epigenetics; 2016 Nov; 11(11):780-790. PubMed ID: 27593557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of both FHIT and p53 cooperate in deregulating proliferation-related pathways in lung cancer.
    Andriani F; Roz E; Caserini R; Conte D; Pastorino U; Sozzi G; Roz L
    J Thorac Oncol; 2012 Apr; 7(4):631-42. PubMed ID: 22425911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma.
    Ryu HS; Chung JH; Lee K; Shin E; Jing J; Choe G; Kim H; Xu X; Lee HE; Kim DG; Lee H; Jang JJ
    Hum Pathol; 2012 Dec; 43(12):2360-70. PubMed ID: 23084587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
    Wang X; Zhang J; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrahepatic cholangiocarcinoma with sarcomatous change. Clinicopathologic and immunohistochemical evaluation of seven cases.
    Nakajima T; Tajima Y; Sugano I; Nagao K; Kondo Y; Wada K
    Cancer; 1993 Sep; 72(6):1872-7. PubMed ID: 7689920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation analysis and copy number changes of KRAS and BRAF genes in Taiwanese cases of biliary tract cholangiocarcinoma.
    Huang WC; Tsai CC; Chan CC
    J Formos Med Assoc; 2017 Jun; 116(6):464-468. PubMed ID: 27745798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of sarcomatoid combined hepatocellular-cholangiocarcinoma].
    Jeong BJ; Hyun DH; Lee KW; Ryu ST; Lee JW; Lee JI; Jeong S; Lee DH; Kim PS; Kim HG; Kim YS; Kim JM
    Korean J Gastroenterol; 2004 Jan; 43(1):56-60. PubMed ID: 14745254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FHIT promotes the apoptosis of QBC939 by reducing the expression of cyclin D1.
    Huang Q; Xie F; Tang Z; Liu C; Wang C; Hu Y; Qiu L; Wang S; You H; Zhu K; Xu P
    Hepatogastroenterology; 2011; 58(107-108):713-8. PubMed ID: 21830375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of E-cadherin and β-catenin in two cholangiocarcinoma cell lines (OZ and HuCCT1) with different degree of invasiveness of the primary tumor.
    Abuetabh Y; Persad S; Nagamori S; Huggins J; Al-Bahrani R; Sergi C
    Ann Clin Lab Sci; 2011; 41(3):217-23. PubMed ID: 22075503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and characterization of mouse mammary carcinoma cell lines expressing RET with a multiple endocrine neoplasia 2A mutation.
    Kawai K; Jijiwa M; Shimono Y; Kurokawa K; Murakumo Y; Ichihara M; Takahashi M
    Cancer Sci; 2003 Nov; 94(11):992-7. PubMed ID: 14611677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGR5 promotes cholangiocarcinoma by interacting with mortalin.
    Li AD; Xie XL; Qi W; Wang WB; Ma JJ; Zhao DQ; Jiang XY; Chen L; Bai Y; Jiang HQ
    Exp Cell Res; 2020 Apr; 389(2):111855. PubMed ID: 31978385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
    Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
    J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer related gene alterations can be detected with next-generation sequencing analysis of bile in diffusely infiltrating type cholangiocarcinoma.
    Lee CH; Wang HE; Seo SY; Kim SH; Kim IH; Kim SW; Lee ST; Kim DG; Han MK; Lee SO
    Exp Mol Pathol; 2016 Aug; 101(1):150-6. PubMed ID: 27460275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition.
    Lien HC; Hsiao YH; Lin YS; Yao YT; Juan HF; Kuo WH; Hung MC; Chang KJ; Hsieh FJ
    Oncogene; 2007 Dec; 26(57):7859-71. PubMed ID: 17603561
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Nabeshima T; Hamada S; Taguchi K; Tanaka Y; Matsumoto R; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G419-G427. PubMed ID: 31961719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.